Ownership

Avalon Ventures XI, L.P. - 10%+ Owner at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: JANX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Avalon Ventures XI, L.P. - trading volume in the past year for Janux Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-4.17M	100%	$49.20	-$205M
Net	-4.17M	-100%		-$205M

Holdings reported by Avalon Ventures XI, L.P. for Janux Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	2.79M	$141M	$50.61	Oct 16, 2024	By Avalon BioVentures SPV I, LP
Common Stock	2.12M	$94.7M	$44.75	Oct 18, 2024	By Avalon BioVentures SPV I, L.P.
Common Stock	2.07M	$92.7M	$44.75	Oct 18, 2024	Direct
Common Stock	401K	$18M	$44.75	Oct 18, 2024	By Avalon BioVentures I, LP
Stock Option (right to buy)	6.07K			Oct 17, 2024	Direct	Common Stock

Transactions reported by Avalon Ventures XI, L.P. for Janux Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.